Company UpdateGeneral
Jenburkt Pharmaceuticals shares admitted to NSE 'Permitted to Trade' category from 17 August 2026
Admission to NSE 'Permitted to Trade' category
- NSE circular permits Jenburkt's equity shares to trade under 'Permitted to Trade' from 17 Aug 2026.
- The company has not applied for NSE listing; shares remain listed on BSE.
- No separate communication was received from NSE; the company learned of the circular later.
- Trading on NSE does not affect governance, capital structure, or the company's listing status.
- This intimation is for information and records of exchange, shareholders, and stakeholders.